The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
The global DNA Vaccines market was valued at US$ 4642 million in 2023 and is anticipated to reach US$ 7849.6 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines.
Report Scope
The DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 DNA Vaccines Market Overview
1.1 Product Overview and Scope of DNA Vaccines
1.2 DNA Vaccines Segment by Type
1.2.1 Global DNA Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 DNA Vaccines Segment by Application
1.3.1 Global DNA Vaccines Market Value by Application: (2024-2030)
1.3.2 Human
1.3.3 Animal
1.4 Global DNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global DNA Vaccines Revenue 2019-2030
1.4.2 Global DNA Vaccines Sales 2019-2030
1.4.3 Global DNA Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 DNA Vaccines Market Competition by Manufacturers
2.1 Global DNA Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global DNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global DNA Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global DNA Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DNA Vaccines, Product Type & Application
2.7 DNA Vaccines Market Competitive Situation and Trends
2.7.1 DNA Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DNA Vaccines Players Market Share by Revenue
2.7.3 Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DNA Vaccines Retrospective Market Scenario by Region
3.1 Global DNA Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global DNA Vaccines Global DNA Vaccines Sales by Region: 2019-2030
3.2.1 Global DNA Vaccines Sales by Region: 2019-2024
3.2.2 Global DNA Vaccines Sales by Region: 2025-2030
3.3 Global DNA Vaccines Global DNA Vaccines Revenue by Region: 2019-2030
3.3.1 Global DNA Vaccines Revenue by Region: 2019-2024
3.3.2 Global DNA Vaccines Revenue by Region: 2025-2030
3.4 North America DNA Vaccines Market Facts & Figures by Country
3.4.1 North America DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America DNA Vaccines Sales by Country (2019-2030)
3.4.3 North America DNA Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe DNA Vaccines Market Facts & Figures by Country
3.5.1 Europe DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe DNA Vaccines Sales by Country (2019-2030)
3.5.3 Europe DNA Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DNA Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific DNA Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific DNA Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America DNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America DNA Vaccines Sales by Country (2019-2030)
3.7.3 Latin America DNA Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa DNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa DNA Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa DNA Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global DNA Vaccines Sales by Type (2019-2030)
4.1.1 Global DNA Vaccines Sales by Type (2019-2024)
4.1.2 Global DNA Vaccines Sales by Type (2025-2030)
4.1.3 Global DNA Vaccines Sales Market Share by Type (2019-2030)
4.2 Global DNA Vaccines Revenue by Type (2019-2030)
4.2.1 Global DNA Vaccines Revenue by Type (2019-2024)
4.2.2 Global DNA Vaccines Revenue by Type (2025-2030)
4.2.3 Global DNA Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global DNA Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global DNA Vaccines Sales by Application (2019-2030)
5.1.1 Global DNA Vaccines Sales by Application (2019-2024)
5.1.2 Global DNA Vaccines Sales by Application (2025-2030)
5.1.3 Global DNA Vaccines Sales Market Share by Application (2019-2030)
5.2 Global DNA Vaccines Revenue by Application (2019-2030)
5.2.1 Global DNA Vaccines Revenue by Application (2019-2024)
5.2.2 Global DNA Vaccines Revenue by Application (2025-2030)
5.2.3 Global DNA Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global DNA Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck DNA Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK DNA Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi DNA Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoties DNA Vaccines Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco DNA Vaccines Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indian Immunologicals DNA Vaccines Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DNA Vaccines Industry Chain Analysis
7.2 DNA Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DNA Vaccines Production Mode & Process
7.4 DNA Vaccines Sales and Marketing
7.4.1 DNA Vaccines Sales Channels
7.4.2 DNA Vaccines Distributors
7.5 DNA Vaccines Customers
8 DNA Vaccines Market Dynamics
8.1 DNA Vaccines Industry Trends
8.2 DNA Vaccines Market Drivers
8.3 DNA Vaccines Market Challenges
8.4 DNA Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
*If Applicable.